Z-ATAD-FMK

Z-ATAD-FMK is a synthetic peptide-based inhibitor specifically designed to target caspase enzymes, particularly caspase-12, through irreversible binding. As a fluoromethyl ketone (FMK) derivative, it features a benzyloxycarbonyl (Z) protective group and an ATAD peptide sequence, which together confer high selectivity and stability in biochemical systems. The compound is highly valued in apoptosis research for its ability to modulate programmed cell death pathways, enabling precise dissection of caspase-dependent cellular mechanisms. Its utility extends to studies of endoplasmic reticulum (ER) stress responses and neurodegeneration, making it a powerful tool for elucidating the molecular underpinnings of cell fate decisions in diverse biological contexts.

Apoptosis pathway analysis: Z-ATAD-FMK is widely employed in the investigation of apoptotic signaling, particularly in mapping the role of caspase-12 and related proteases during programmed cell death. By irreversibly inhibiting specific caspases, the compound allows researchers to delineate the contribution of these enzymes to apoptosis initiation and execution. This facilitates the identification of upstream and downstream effectors, providing mechanistic insights into cell death regulation and the interplay between caspase-dependent and independent pathways.

Endoplasmic reticulum stress studies: The compound serves as a crucial tool for probing ER stress-induced apoptosis. Caspase-12 is a key mediator of cell death in response to ER stress, and selective inhibition by Z-ATAD-FMK enables the assessment of its functional role in the unfolded protein response. Researchers use this inhibitor to distinguish caspase-12-dependent events from alternative stress-induced signaling cascades, thereby clarifying the molecular events that govern cellular adaptation or demise under conditions of protein misfolding or calcium dysregulation.

Neurodegeneration research: In models of neurodegenerative disease, such as Alzheimer's and Parkinson's, caspase-mediated pathways are often implicated in neuronal loss. Z-ATAD-FMK is utilized to dissect the involvement of caspase-12 and related proteases in neurotoxicity and synaptic dysfunction. By selectively blocking these enzymes, it becomes possible to evaluate their contribution to disease progression, neuronal resilience, and the balance between survival and apoptosis in neural tissues.

Inflammatory response modulation: Beyond its role in apoptosis, the inhibitor is also investigated for its effects on inflammatory signaling. Caspase-12 has been associated with modulation of inflammatory cytokine production, and selective inhibition with Z-ATAD-FMK allows for controlled studies of cytokine processing, inflammasome activation, and the resolution of inflammation. This application is particularly relevant in cellular models where distinguishing between apoptotic and inflammatory pathways is essential for understanding immune regulation.

Peptide inhibitor validation: As a structurally defined peptide-based caspase inhibitor, Z-ATAD-FMK is frequently used as a positive control or benchmark in the development and validation of novel protease inhibitors. Its well-characterized mechanism of action and specificity make it an ideal reference compound in biochemical assays, substrate screening, and inhibitor profiling. This supports the optimization of assay conditions and the accurate interpretation of experimental outcomes in protease-targeted research.

1. Implications of ligand-receptor binding kinetics on GLP-1R signalling

2. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

3. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

4. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

5. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance